Envoy Medical (COCH) Net Cash Flow (2022 - 2026)
Envoy Medical's Net Cash Flow history spans 5 years, with the latest figure at $21.5 million for Q1 2026.
- On a quarterly basis, Net Cash Flow rose 12254.24% to $21.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $19.9 million, a 5378.85% increase, with the full-year FY2025 number at -$1.7 million, down 237.67% from a year prior.
- Net Cash Flow hit $21.5 million in Q1 2026 for Envoy Medical, up from $183000.0 in the prior quarter.
- Over the last five years, Net Cash Flow for COCH hit a ceiling of $21.5 million in Q1 2026 and a floor of -$12.6 million in Q4 2023.
- Historically, Net Cash Flow has averaged $1.4 million across 5 years, with a median of -$22740.0 in 2022.
- Biggest five-year swings in Net Cash Flow: crashed 2904.76% in 2023 and later surged 12254.24% in 2026.
- Tracing COCH's Net Cash Flow over 5 years: stood at -$420000.0 in 2022, then crashed by 2904.76% to -$12.6 million in 2023, then soared by 108.4% to $1.1 million in 2024, then tumbled by 82.74% to $183000.0 in 2025, then surged by 11655.74% to $21.5 million in 2026.
- Business Quant data shows Net Cash Flow for COCH at $21.5 million in Q1 2026, $183000.0 in Q4 2025, and -$1.7 million in Q3 2025.